AML helps its customers to achieve their goals, such as designing custom orthotic devices for amputees, delivering more accountable wound care, and helping clinical product development companies to gain regulatory approval.
The team takes each product from concept to manufacture to customer, and has an enviable international reputation for precision, service and quality.
AML is a pioneer in transformative health care; disrupting primitive traditional assessment methods with leading edge, comprehensive solutions that lead to better patient outcomes, and more effective and accurate clinical processes.
AML’s main geographic market is the United States (US). It also has customers in the Middle East, the United Kingdom, Australia, Canada, Europe, Asia and New Zealand.
Customers include Smith and Nephew, the Department of Veterans Affairs, Hanger Orthopedic Group, and large US health systems.
AML’s solutions are targeted at two main international markets:
- Silhouette is used for wound care in clinical practice (a $50 billion market in the US alone) and clinical research (used in more than 40 clinical trials);
- FastSCAN supports orthotics/prosthetics design and manufacture and other scanning applications.
The technology’s commercial success was set in motion more than a decade ago with an ingenious handheld digital scanning device initially used by Weta Digital in the creation of digital models for creatures in The Lord of the Rings film trilogy.
Today, AML’s state-of-the-art technology is addressing a range of challenging medical problems. The founders are still active in the development of emerging AML technologies.
AML is a fast-growing company that attracts top talent and takes emerging technologies into mainstream clinical environments.
The growing team in Christchurch, New Zealand, is tasked with research and development, engineering in hardware and software, manufacturing, sales, quality and regulatory activities. Head office functions are complemented by a growing distributor network.
Research and development
AML invests a significant amount of its annual revenue into research and development and holds a number of patents.
The advanced development team finds the way forward; exploring new opportunities and creating technical stretch over our current products and the competition. Prototypes are then developed and transferred to engineering where the hardware and software are readied for commercial release.
The software development team also releases systematic updates and upgrades; constantly improving the informatics capability and usability of the system.
AML is a Microsoft Partner and uses the latest tools, such as Visual Studio and .NET, in short, iterative development cycles.
Our technologies are TUV and FDA approved and comply with all major health information technology requirements (such as HIPAA, REACH and PMCF). Solutions can involve integration with major electronic medical record (EMR) and research documentation systems.
Roles within the company and company culture
AML works in small teams utilising advanced development, agile software development and electrical engineering. The team includes specialists in:
- medical imaging and informatics
- sales, marketing and business development
- quality and regulatory management
- 3D surface acquisition technology
- electrical, system and software engineering
- product management and rapid development
- clinical development and commercialisation.
A significant number of the team hold PhDs and contribute significantly to the company’s innovative firepower.
The culture of the company is dynamic, friendly and customer focused, with ample opportunities for professional development. The company is low on ceremony and high on output, and prefers to work collaboratively.
View the video interview with the Systems Engineer at ARANZ Medical